MetLife Investment Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833K | Buy |
26,358
+3,579
| +16% | +$113K | ﹤0.01% | 1405 |
|
|
2025
Q1 | $756K | Sell |
22,779
-348
| -2% | -$11.6K | ﹤0.01% | 1500 |
|
|
2024
Q4 | $796K | Buy |
23,127
+5,242
| +29% | +$180K | ﹤0.01% | 1537 |
|
|
2024
Q3 | $715K | Sell |
17,885
-1,397
| -7% | -$55.9K | ﹤0.01% | 1584 |
|
|
2024
Q2 | $582K | Buy |
19,282
+1,735
| +10% | +$52.3K | ﹤0.01% | 1642 |
|
|
2024
Q1 | $589K | Hold |
17,547
| – | – | ﹤0.01% | 1585 |
|
|
2023
Q4 | $567K | Hold |
17,547
| – | – | ﹤0.01% | 1612 |
|
|
2023
Q3 | $575K | Hold |
17,547
| – | – | ﹤0.01% | 1546 |
|
|
2023
Q2 | $617K | Buy |
17,547
+3,275
| +23% | +$115K | ﹤0.01% | 1561 |
|
|
2023
Q1 | $466K | Hold |
14,272
| – | – | ﹤0.01% | 1688 |
|
|
2022
Q4 | $786K | Hold |
14,272
| – | – | 0.01% | 1344 |
|
|
2022
Q3 | $632K | Hold |
14,272
| – | – | 0.01% | 1466 |
|
|
2022
Q2 | $696K | Buy |
14,272
+575
| +4% | +$28K | 0.01% | 1435 |
|
|
2022
Q1 | $666K | Buy |
13,697
+4,360
| +47% | +$212K | ﹤0.01% | 1599 |
|
|
2021
Q4 | $398K | Hold |
9,337
| – | – | ﹤0.01% | 1630 |
|
|
2021
Q3 | $358K | Hold |
9,337
| – | – | ﹤0.01% | 1721 |
|
|
2021
Q2 | $264K | Buy |
+9,337
| New | +$264K | ﹤0.01% | 1979 |
|